Book
Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model
| العنوان: | Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model |
|---|---|
| المؤلفون: | Sohn Joo Ahn, Yong Hyun Jeon, Yong Jin Lee, You La Lee, Sang-Woo Lee, Byeong-Cheol Ahn, Jeoung-Hee Ha, Jaetae Lee |
| المصدر: | Nature Precedings |
| سنة النشر: | 2009 |
| المجموعة: | Nature Precedings |
| مصطلحات موضوعية: | Cancer |
| الوصف: | Using an adenoviral system as a delivery mediator of therapeutic gene, we investigated the therapeutic effects of the use of combined _MDR1_ shRNA and human _NIS_ (hNIS) radioiodine gene therapy in a mouse colon xenograft model. _In vitro_ uptake of Tc-99m sestamibi was increased approximately two-fold in cells infected with an adenovirus vector that expressed _MDR1_ shRNA (Ad-shMDR) and I-125 uptake was 25-fold higher in cells infected with an adenovirus vector that expressed human _NIS_ (Ad-hNIS) as compared to control cells. As compared with doxorubicin or I-131 treatment alone, the combination of doxorubicin and I-131 resulted in enhanced cytotoxicity for both Ad-shMDR and Ad-hNIS infected cells but not for control cells. In vivo uptake of Tc-99m sestamibi and Tc-99m pertechnetate was two-fold and 10-fold higher for Ad-shMDR and Ad-hNIS-infected tumors as compared to tumors infected with a control adenovirus construct that expressed [beta]-galactrosidase (Ad-LacZ), respectively. In mice treated with either doxorubicin or I-131 alone, there was a slight delay in tumor growth as compared to mice treated with Ad-LacZ. However, combination therapy with doxorubicin and I-131 induced further significant inhibition of tumor growth as compared with mice treated with Ad-LacZ. We have demonstrated successful therapeutic efficacy of combined MDR shRNA and hNIS radioiodine gene therapy using an adenoviral vector system in a mouse colon cancer model. Adenovirus-mediated cancer gene therapy using MDR1 shRNA and hNIS would be a useful tool for the treatment of cancer cells expressing multi-drug resistant genes. |
| نوع الوثيقة: | manuscript |
| اللغة: | unknown |
| Relation: | http://precedings.nature.com/documents/3307/version/1; oai:nature.com:10101/npre.2009.3307.1; http://hdl.handle.net/10101/npre.2009.3307.1 |
| الاتاحة: | http://precedings.nature.com/documents/3307/version/1 http://hdl.handle.net/10101/npre.2009.3307.1 |
| Rights: | Creative Commons Attribution 3.0 License |
| رقم الانضمام: | edsbas.8E0C32AF |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |